Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

409

HTML

4147

Figures (1-2)

220

Tables (1-3)

186

Sum=4962

Oct 1, 2004 (publication date) through Nov 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Oct 1, 2004; 10(19): 2878-2882
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2878

Figure 1 Mean plasma vascular endothelial growth factor levels at each disease stage in patients with hepatocellular carcinoma.

Figure 2 Effect of TACE on mean plasma vascular endothelial growth factor levels.

Citation: Li X, Feng GS, Zheng CS, Zhuo CK, Liu X. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level. World J Gastroenterol 2004; 10(19): 2878-2882
URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2878.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2878